Atossa Therapeutics
ATOS
#10322
Rank
โ‚ฌ18.3 M
Marketcap
2,13ย โ‚ฌ
Share price
-4.84%
Change (1 day)
185.65%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -โ‚ฌ26.87 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ22.04 Million, an increase over its 2023 earnings that were of -โ‚ฌ26.01 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ26.87 Million21.89%
2024 -โ‚ฌ22.04 Million-15.25%
2023 -โ‚ฌ26.01 Million11.62%
2022 -โ‚ฌ23.3 Million30.84%
2021 -โ‚ฌ17.81 Million15.58%
2020 -โ‚ฌ15.41 Million3.41%
2019 -โ‚ฌ14.9 Million51.16%
2018 -โ‚ฌ9.86 Million40.41%
2017 -โ‚ฌ7.02 Million27.54%
2016 -โ‚ฌ5.51 Million-47.49%
2015 -โ‚ฌ10.49 Million-17.25%
2014 -โ‚ฌ12.67 Million35.91%
2013 -โ‚ฌ9.32 Million112.3%
2012 -โ‚ฌ4.39 Million46.53%
2011 -โ‚ฌ3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.44 B-86,180.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ1.18 B-4,659.31%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ1.18 B-4,656.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚ฌ36.01 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚ฌ85.94 Million 229.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚ฌ6.78 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA